Results 21 to 30 of about 39,059 (218)

Long-Term Survival Following Nivolumab Treatment in Pulmonary Tumour Thrombotic Microangiopathy Associated With Cancer of Unknown Primary: A Case Report. [PDF]

open access: yesRespirol Case Rep
Pulmonary tumour thrombotic microangiopathy (PTTM) is a rapidly fatal condition that is rarely diagnosed during life. Early clinical recognition and prompt nivolumab treatment resulted in long‐term survival in a patient with cancer of unknown primary‐associated PTTM.
Fujishima K   +4 more
europepmc   +2 more sources

The role of acetylcholine neurotransmission in the pharmacotherapy of cognitive dysfunction

open access: yesОбозрение психиатрии и медицинской психологии имени В.М. Бехтерева, 2018
Microangiopathy and deficit in cholinergic system innervating cerebral cortex and controlling the plasticity of neuronal structuresplay an important role in the formation of cognitive disorders.
D. V. Zaharov, V. A. Mihailov
doaj   +1 more source

Survival of Split Thickness Skin Graft in Diabetic and Non-diabetic Wound Management [PDF]

open access: yesInternational Journal of Anatomy Radiology and Surgery, 2016
Introduction: Split skin grafting is widely used surgical procedure for the treatment of ulcers. Graft survival depends on number of factors like vascularity, wound infection etc. diabetes is associated with endothelial dysfunction, neuropathy, wound
Maramreddy Revanth   +4 more
doaj   +1 more source

Depression in patients with cerebral microangiopathy

open access: yesНеврология, нейропсихиатрия, психосоматика, 2023
Cerebral microangiopathy (CMA) is one of the significant causes of depression in the elderly. Close associations of the risk of developing depression with white matter hyperintensity, the presence of lacunar infarcts, and other markers of vascular ...
A. N. Bogolepova
doaj   +1 more source

THROMBOTIC MICROANGIOPATHY IN THE PATHOGENESIS OF OBSTETRIC COMPLICATIONS [PDF]

open access: yes, 2016
Thrombotic microangiopathy is one of the most serious thrombotic complications characterized by microvascular thrombosis in various organs and accompanied by thrombocytopenia and hemolytic anemia.
A. D. Makatsariya   +3 more
core   +1 more source

Automatic assessment of nailfold capillaroscopy software: a pilot study

open access: yesRheumatology
Introduction Capillaroscopy is a simple method of nailfold capillary imaging, used to diagnose diseases from the systemic sclerosis spectrum. However, the assessment of the capillary image is time-consuming and subjective.
Olga Elżbieta Brzezińska   +2 more
doaj   +1 more source

Carfilzomib-Induced Thrombotic Microangiopathy: Focus on Pathogenesis

open access: yes, 2022
Drug-induced thrombotic microangiopathies present in similar fashion but have varied pathogenic mechanisms. Carfilzomib is an irreversible proteasome inhibitor.
Hermelin, Daniela   +2 more
core   +2 more sources

Pilot Study of Diagnostic Performances of Vascular Biomarkers Soluble fms-Like Tyrosine Kinase and Placental Growth Factor in Scleroderma Renal Crisis

open access: yesKidney International Reports
Introduction: Scleroderma renal crisis (SRC) is a major vascular complication of systemic sclerosis (SSc), associated with high morbidity and mortality.
Aïcha Kante   +12 more
doaj   +1 more source

Thrombotic thrombocytopenic purpura as a rare cause of anemia with thrombocytopenia in childhood: report of 2 cases

open access: yesThe Turkish Journal of Pediatrics, 2019
Thrombotic thrombocytopenic purpura (TTP) is a rare multisystem disorder characterized by single or recurrent episodes of thrombocytopenia, microangiopathic hemolytic anemia and widespread microvascular thrombosis, which causes significant morbidity and
Oya Köker   +3 more
doaj   +1 more source

Onasemnogene Abeparvovec in Patients With SMA: Interim Results of the RESTORE Registry in Japan

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective There are limited real‐world data regarding the safety and effectiveness of onasemnogene abeparvovec (OA; Zolgensma) infusion, a one‐time gene replacement therapy, for Japanese patients with spinal muscular atrophy (SMA). We aimed to improve understanding of the real‐world outcomes for OA in Japan.
Kayoko Saito   +8 more
wiley   +1 more source

Home - About - Disclaimer - Privacy